Trial
NCT06663046
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Wondercel Biotech (ShenZhen)
Collaborators
—
Condition
Multiple Myleoma
Intervention
Single dose injection of certain dose of UWD-00B
Why stopped
Because the implementation of the new regulation policy by the Chinese authority
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-07